Attached files

file filename
8-K/A - FORM 8-K/A - ICAD INCc14319e8vkza.htm
EX-23.1 - EXHIBIT 23.1 - ICAD INCc14319exv23w1.htm
EX-99.1 - EXHIBIT 99.1 - ICAD INCc14319exv99w1.htm
Exhibit 99.2
UNAUDITED PRO FORMA COMBINED CONDENSED FINANCIAL INFORMATION
Introduction
On December 30, 2010 (the “Closing Date”), iCAD, Inc. (the “Company”) completed its acquisition of Xoft, Inc. (“Xoft”), a privately held company based in California. Xoft designs, develops, manufactures, markets and sells electronic brachytherapy (eBx) products for the treatment of breast and other cancers, used in a broad range of clinical settings. The acquisition was made pursuant to an Agreement and Plan of Merger dated December 15, 2010, by and between the Company, XAC, Inc., a wholly-owned subsidiary of the Company (“Merger Sub”), Xoft and Jeffrey Bird as the representative of the stockholders of Xoft (“Merger Agreement”). Upon the terms of the Merger Agreement, Xoft was merged with and into the Merger Sub with the Merger Sub surviving the merger (the “Merger”).
The Company acquired 100% of the outstanding stock of Xoft in exchange for approximately 8.35 million shares of the Company’s common stock and approximately $1.2 million in cash, for a total consideration at closing of approximately $12.9 million based on a per share value of $1.40, the closing price of the Company’s common stock on the closing date. The Company also paid certain transaction expenses of Xoft totaling approximately $1.0 million which is included in the Company statement of operations. Xoft stockholders now own approximately 15.4% of the Company’s common stock.
Under the Merger Agreement, there is an additional earn-out potential for the sellers that is tied to cumulative net revenue of Xoft products over the next three years, payable at the end of that period. The threshold for earn-out consideration begins at $50 million of cumulative revenue of “Xoft Products” (as defined in the Merger Agreement) over the three year period immediately following the closing. The “targeted” earn-out consideration of $20 million will occur at $76 million of cumulative revenue of Xoft Products and the maximum earn-out consideration of $40 million would be achieved at $104 million of cumulative revenue of Xoft Products over the three year period. The Company recorded a contingent consideration liability of $5,000,000.
At closing, 10% of the cash amount and 10% of the amount of the Company’s common stock comprising the merger consideration was placed in escrow. It will remain in escrow for a period of 15 months following the closing of the Merger to secure post-closing indemnification obligations of Xoft stockholders.
The following unaudited pro forma combined condensed financial information gives effect to the merger of the Company and Xoft using the purchase method of accounting, as required by Accounting Standards Codification (“ASC”) 805, “Business Combinations.” Under this method of accounting, the Company allocated the purchase price to the fair value of assets acquired, including identified intangible assets and goodwill. The purchase price allocation is subject to revision when the Company obtains additional information regarding its purchased asset valuation. The unaudited pro forma combined condensed balance sheet assumes the Merger took place on September 30, 2010. The unaudited pro forma combined condensed statements of operations assume that the Merger took place as of January 1, 2009.
The financial information presented in the unaudited pro forma combined condensed financial statements is based on amounts and adjustments that the Company’s management believes to be factually supportable. The Company has made no attempt to included forward looking assumptions in such information.

 

 


 

Certain reclassifications have been made to Xoft’s historical presentation to conform to the Company’s presentation. These reclassifications do not materially impact the unaudited pro forma condensed consolidated results of operations for the periods presented.
The unaudited pro forma adjustments, which are based upon available information and upon certain assumptions that the Company believes are reasonable, are described in the accompanying notes. The Company is providing the unaudited pro forma condensed consolidated financial information for informational purposes only. The companies may have performed differently had they been combined during the periods presented. You should not rely on the unaudited pro forma combined condensed financial information as being indicative of the historical results that would have been achieved had the companies actually been combined during the periods presented or the future results that the combined companies will experience. The unaudited pro forma combined condensed statements of operations do not give effect to any cost savings or operating synergies expected to result from the acquisitions or the costs to achieve such cost savings or operating synergies.

 

 


 

Unaudited Pro Forma Combined Condensed Balance Sheet
As of September 30, 2010
(Unaudited)
                                 
                            Proforma  
    Historical     Proforma     Combined  
    iCAD     Xoft     Adjustments     Total  
Assets
                               
Current assets:
                               
Cash and equivalents
  $ 18,115,731     $ 87,603       (1,183,162 ) (a)   $ 17,020,172  
Trade accounts receivable, net of allowance
    3,118,398       1,116,467             4,234,865  
Inventory
    701,507       2,918,776       (181,148 ) (c)     3,439,135  
Prepaid and other
    503,270       1,054,200       (677,619 ) (d)     879,851  
 
                       
Total current assets
    22,438,906       5,177,046       (2,041,929 )     25,574,023  
 
                       
 
                               
Property and equipment:
                               
Equipment
    2,848,598       4,931,475       (474,255 ) (e)     7,305,818  
Leasehold improvements
    74,107       931,403             1,005,510  
Furniture and fixtures
    344,700       111,439             456,139  
Marketing assets
    292,613       32,119             324,732  
 
                       
 
    3,560,018       6,006,436       (474,255 )     9,092,199  
Less accumulated depreciation and amortization
    2,773,640       3,453,870             6,227,510  
 
                       
Net property and equipment
    786,378       2,552,566       (474,255 )     2,864,689  
 
                       
 
                               
Other assets:
                               
Deposits
    32,126       731,826               763,952  
Patents, net
    118,536       1,680,938             1,799,474  
Tradename, net
    80,600                   80,600  
Technology intangible, net
    5,261,636             14,200,000 (b)     19,461,636  
Customer relations, net
    175,894                   175,894  
Goodwill
    43,515,285             1,304,857 (b)     44,820,142  
 
                       
Total other assets
    49,184,077       2,412,764       15,504,857       67,101,698  
 
                       
 
                               
Total assets
  $ 72,409,361     $ 10,142,376       12,988,673     $ 95,540,410  
 
                       
 
                               
Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity
                               
 
                               
Current liabilities:
                               
Accounts payable
  $ 1,109,758     $ 1,229,196           $ 2,338,954  
Accrued interest payable
          2,074,962       (2,074,962 ) (f)      
Accrued salaries and other expenses
    2,704,726       979,628             3,684,354  
Deferred revenue
    3,912,418       2,959,575       (1,711,524 ) (g)     5,160,469  
Deferred rent
            110,736       233,462 (h)     344,198  
Settlement costs
            463,080             463,080  
Borrowings, net
          17,963,918       (17,963,918 ) (f)      
 
                       
Total current liabilities
    7,726,902       25,781,095       (21,516,942 )     11,991,055  
 
                               
Contingent consideration liability
                5,000,000 (a)     5,000,000  
Long term deferred revenue
    479,035       877,256       (218,468 ) (g)     1,137,823  
Long term deferred rent
            184,526       217,040 (h)     401,566  
Long term warranty costs
    17,088                   17,088  
Long term settlement costs and other long term liabilities
          1,147,042       (36,750 ) (i)     1,110,292  
 
                       
Total liabilities
    8,223,025       27,989,919       (16,555,120 )     19,657,824  
 
                       
 
                               
Redeemable convertible preferred stock:
                             
Preferred stock
          99,619,698       2,074,962 (f)        
 
                    17,963,918 (f)        
 
                    (119,658,578 ) (j)      
 
                       
Stockholders’ equity (deficit):
                               
Common stock
    460,125       8,264       (8,264 ) (j)        
 
                    83,485 (a)     543,610  
Additional paid-in capital
    151,251,081       23,555,348       (23,555,348 ) (j)        
 
                    11,612,765 (a)     162,863,846  
Accumulated deficit
    (86,574,606 )     (141,030,853 )     141,030,853 (j)     (86,574,606 )
Treasury stock at cost (67,876 shares)
    (950,264 )                 (950,264 )
 
                       
Stockholders’ equity (deficit)
    64,186,336       (117,467,241 )     129,163,491       75,882,586  
 
                       
 
                               
Total liabilities, redeemable convertible preferred stock and stockholders’ equity
  $ 72,409,361     $ 10,142,376       12,988,673     $ 95,540,410  
 
                       
See accompanying introduction and notes to unaudited pro forma combined condensed financial statements.

 

PF1


 

Unaudited Pro Forma Combined Condensed Statement of Operations
For the nine months ended September 30, 2010
(Unaudited)
                                 
                            Proforma  
    Historical     Proforma     Combined  
    iCAD     Xoft     Adjustments     Total  
 
                               
Total revenue
  $ 18,204,165     $ 4,243,260             $ 22,447,425  
 
                               
Total cost of revenue
    2,282,176       5,108,063       (1,657,122 )(l)     5,733,117  
 
                               
 
                       
Gross margin
    15,921,989       (864,803 )     1,657,122       16,714,308  
 
                       
 
                               
Operating expenses:
                               
Engineering and product development
    4,795,946       2,195,470       1,065,000 (k)        
 
                    1,408,958 (l)     9,465,374  
Sales, general and administrative
    14,772,472       5,796,272       248,164 (l)        
 
                    (435,608 )(m)     20,381,300  
 
                       
Total operating expenses
    19,568,418       7,991,742       2,286,514       29,846,674  
 
                               
 
                       
Loss from operations
    (3,646,429 )     (8,856,545 )     (629,392 )     (13,132,366 )
 
                               
Interest and other income (expense), net
    333,117       (1,632,494 )     1,235,141 (f)     (64,236 )
 
                               
 
                       
Net loss available to common stockholders
  $ (3,313,312 )   $ (10,489,039 )   $ 605,749     $ (13,196,602 )
 
                       
 
                               
Net loss per share:
                               
Basic and diluted
    (0.07 )                   $ (0.24 )
 
                               
Weighted average number of shares used in computing loss per share:
                               
Basic and diluted
    45,782,449               8,348,501 (n)     54,130,950  
See accompanying introduction and notes to unaudited pro forma combined condensed financial statements.

 

PF2


 

Unaudited Pro Forma Combined Condensed Statement of Operations
For the year ended December 31, 2009
(Unaudited)
                                 
                            Proforma  
    Historical     Proforma     Combined  
    iCAD     Xoft     Adjustments     Total  
 
                               
Total revenue
  $ 28,109,265     $ 5,906,541             $ 34,015,806  
 
                               
Total cost of revenue
    4,621,784       9,099,486       (2,660,653 )(l)     11,060,617  
 
                               
 
                       
Gross margin
    23,487,481       (3,192,945 )     2,660,653       22,955,189  
 
                       
 
                               
Operating expenses:
                               
Engineering and product development
    7,217,146       4,203,628       1,420,000 (k)        
 
                    2,329,768 (l)     15,170,542  
Sales, general and administrative
    18,391,301       11,275,189       330,885 (l)     29,997,375  
 
                       
Total operating expenses
    25,608,447       15,478,817       4,080,653       45,167,917  
 
                               
 
                       
Loss from operations
    (2,120,966 )     (18,671,762 )     (1,420,000 )     (22,212,728 )
 
                               
Interest and other income (expense), net
    109,772       (1,722,538 )     839,821 (f)     (772,945 )
 
                               
 
                       
Loss before provision (benefit) for income taxes
    (2,011,194 )     (20,394,300 )     (580,179 )     (22,985,673 )
 
                               
Provision (benefit) for income taxes
    (43,570 )                 (43,570 )
 
                               
 
                       
Net loss
  $ (1,967,624 )   $ (20,394,300 )   $ (580,179 )   $ (22,942,103 )
 
                       
 
                               
Net loss per share:
                               
Basic and diluted
  $ (0.04 )                   $ (0.43 )
 
                               
Weighted average number of shares used in computing loss per share:
                               
Basic and diluted
    45,511,883               8,348,501 (n)     53,860,384  
See accompanying introduction and notes to unaudited pro forma combined condensed financial statements.

 

PF3


 

Notes to Unaudited Pro Forma Combined Condensed Financial Information
1. Basis of Pro Forma Presentation
The unaudited pro forma condensed consolidated financial information has been prepared based on the Company’s historical financial information and the historical financial information of Xoft giving effect to the acquisition and related adjustments described in these notes. Certain note disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted as permitted by the SEC rules and regulations.
This unaudited pro forma condensed consolidated financial information is not necessarily indicative of the results of operations that would have been achieved had the acquisition actually taken place at the dates indicated and do not purport to be indicative of future position or operating results.
The unaudited pro forma combined condensed financial information has been prepared on the basis of assumptions relating to the allocation of consideration paid for the acquired assets and liabilities of Xoft based on management’s best preliminary estimates. The actual allocation of the amount of the consideration may differ from that reflected in this unaudited pro forma combined condensed financial information after a third party valuation and other procedures have been completed.
Below are tables of the preliminary estimated purchase price allocation for Xoft:
         
Fair value of the Company’s common stock issued
  $ 11,696,250  
Cash consideration
    1,183,162  
Contingent consideration liability
    5,000,000  
 
     
Total purchase price
  $ 17,879,412  
 
     
 
       
Net tangible assets acquired
  $ 2,374,555  
Estimated fair value of identifiable intangible assets
    14,200,000  
Goodwill
    1,304,857  
 
     
Total Acquisition Cost
  $ 17,879,412  
 
     
2. Pro Forma Adjustments
(a) Adjustments reflect the components of the purchase consideration and related transaction costs which consist of cash consideration of $1,183,162, the Company’s common stock with a market value of $11,696,250 and contingent consideration liability of $5,000,000. The value of the Company’s common stock was based upon a per share value of $1.40, the closing price of the Company’s common stock on the closing date.
(b) Represents adjustments to increase the carrying values of identifiable intangible assets and record goodwill acquired.
(c) Represents certain adjustments to record inventory at fair value.
(d) Reflects the elimination of uncollectible employee advances and deferred cost of goods sold relating to deferred revenue that was eliminated.

 

PF4


 

(e) Represents adjustments to reduce construction in progress associated with building construction and software development that was discontinued.
(f) Reflects the elimination of borrowings by Xoft converted to equity prior to closing and the associated interest expense.
(g) Represents adjustment to deferred revenue to reflect future performance obligation.
(h) Represents adjustment to deferred rent to reflect current market value of lease obligation.
(i) Reflects the elimination of Xoft’s preferred stock warrant liability.
(j) Reflects the elimination of existing stockholders’ deficit of Xoft.
(k) Represents amortization of increase in value of acquired identifiable intangible assets of Xoft based upon average estimated useful lives of ten years (14,200,000/10 years = $1,420,000 per year).
(l) Represents the reclassification of expenses recorded in cost of sales to operating expenses.
(m) Reflects the elimination of legal and professional fees associated with the acquisition.
(n) Reflects the increase in weighted average basic and diluted shares outstanding for the Company’s common stock issued in connection with the Merger. Pro forma basic and diluted loss per share was calculated assuming that the 8,348,501 shares of the Company’s common stock issued in connection with the Merger were issued at the beginning of the period presented.

 

PF5